Bustos, Ingrid G.
Wiscovitch-Russo, Rosana
Singh, Harinder
Sievers, Benjamín L.
Matsuoka, Michele
Freire, Marcelo
Tan, Gene S.
Cala, Mónica P.
Guerrero, Jose L.
Martin-Loeches, Ignacio
Gonzalez-Juarbe, Norberto
Reyes, Luis Felipe
Funding for this research was provided by:
Universidad de La Sabana (MED-289-2020)
Conrad Prebys Foundation (204)
National Institutes for Health (R01AI168313)
National Institutes of Health (R21AI148722)
J. Craig Venter Institute
National Institute of Allergy and Infectious Diseases (AI168313)
Article History
Received: 13 February 2024
Accepted: 5 November 2024
First Online: 12 November 2024
Declarations
:
: The authors declare that they have no competing interests.
: The protocol and informed consent were developed by the Translational Science in Infectious Diseases and Critical Care Medicine (TSID-CCM) research group from Universidad de La Sabana. These were reviewed and authorized by the Institutional Review Board/Independent Ethics Committee (IRB/EC) of the participating institutions. Ethical supervision ensured that informed consent was obtained from all study participants or their authorized representatives. All patients provided informed consent to participate (CUS-20190903).